Background: Repeated remote ischaemic conditioning (RIC) during weaning from cardiopulmonary bypass and in the early postoperative period may confer protection against acute kidney injury (AKI). We evaluated the effect of repeated RIC on the incidence of AKI in patients undergoing valvular heart surgery. Methods: Patients were randomised into either the RIC (n¼120) or control (n¼124) group. A pneumatic tourniquet was placed on each patient's thigh. Upon removal of the aortic cross-clamp, three cycles of inflation for 5 min at 250 mm Hg (with 5 min intervals) were applied in the RIC group. Additionally, three cycles of RIC were repeated at postoperative 12 and 24 h. AKI was diagnosed based on the Kidney Disease: Improving Global Outcomes guideline. The incidences of renal replacement therapy, permanent stroke, sternal wound infection, newly developed atrial fibrillation, mechanical ventilation >24 h, and reoperation for bleeding during hospitalisation were recorded. Results: The incidences of AKI were not significantly different between the control (19.4%) and RIC (15.8%) groups (a difference of 3.5 percentage points; 95% confidence interval: e6.8%e13.9%; P¼0.470). Perioperative serum creatinine concentrations were similar in the control and RIC groups (P¼0.494). Fluid balance, urine output, blood loss, transfusion, and vasopressor/inotropic requirements were not significantly different between the groups (all P>0.05). The occurrences of a composite of morbidity and mortality endpoints were not significantly different between the control (46.0%) and RIC (39.2%) groups (a difference of 6.8 percentage points; 95% confidence interval: e6.4%e20.0%; P¼0.283).
Editor's key points
Remote ischaemic conditioning, typically with a tourniquet applied briefly to a limb, has shown promise in protecting vital organs from ischaemia reperfusion injury. In this single-centre trial, patients undergoing valvular heart surgery were randomised to usual care or to three remote ischaemic conditioning treatments during a 24 h period after cardiopulmonary bypass. There was a non-significant and small decrease in acute renal failure, and a composite of major adverse outcomes in the remote ischaemic conditioning group. As only 244 patients were included in this trial, it remains possible that there is a small but clinically important benefit attributable to remote ischaemic conditioning, which a much larger study might detect.
Acute kidney injury (AKI) occurs in up to 30% of patients undergoing cardiac surgery with cardiopulmonary bypass (CPB), and is strongly associated with increased morbidity and mortality. 1 Despite extensive research, the prevention of AKI after cardiac surgery remains a clinical challenge. Remote ischaemic conditioning (RIC) before CPB was proposed to be a safe, effective intervention to attenuate ischaemia/reperfusion (I/R) injury of major organs, including the prevention of AKI. 2, 3 However, successful clinical translation remains controversial, as two large multicentre randomised trials demonstrated no differences in renal outcome, and in the composite of morbidity endpoints, between the control and pre-CPB RIC group. 4, 5 Heterogeneities in the timing and 'dose' of RIC, and the patients' co-morbidities and anaesthetic regimen, have been suggested to influence the protective efficacy of pre-CPB RIC. 6e9 Notably, most clinical studies have included patients with coronary artery disease, 4, 5 and could have been confounded by preoperative ischaemic episodes conferring direct ischaemic conditioning. 10 Moreover, considering the limited oxygen reserve of the renal medulla, ischaemic insults to the kidney elicited by haemodynamic instability would persist into the postoperative period, with the additional burden of systemic inflammation that usually peaks several hours after CPB. Thus, in the context of AKI prevention, the repeated application of RIC after CPB might be more advantageous than pre-CPB RIC in terms of a more constant delivery of the potentially protective stimulus. Therefore, we hypothesised that repeated application of immediate and delayed RIC during this critical period after CPB might confer a renoprotective effect via sustained conditioning and anti-inflammatory and antioxidant mechanisms. 11, 12 In this randomised controlled trial, we tested whether RIC performed upon the removal of the aortic crossclamp and repeated two times after operation (12 and 24 h) could reduce the incidence of AKI after valvular heart surgery.
Methods

Participants
This study complied with the Declaration of Helsinki, and was approved by our institutional review board and registered at clinicaltrials.gov (NCT02720549 
Study protocol
The subjects were randomly allocated to either the control or RIC group using computer-generated codes with a block size of two. An investigator who was not involved in the care or in the assessment of endpoints confirmed each subject's group assignment, which was contained in an opaque envelope, and performed the RIC or sham RIC intervention. The group assignments were concealed from the attending anaesthesiologists, surgeons, and medical staff who were involved in the perioperative care of the subjects. The other investigators and statisticians were unblinded after the data acquisition from the last participant. RIC was performed upon the removal of aortic cross-clamp, and repeated later at postoperative 12 and 24 h. A pneumatic tourniquet was placed on the thigh of each subject. In the RIC group, three cycles of 5 min inflation at 250 mm Hg and 5 min deflation were applied. In the control group, sham RIC was performed with pseudo-ischaemia at low pressure (20 mm Hg). The operating console of a stand-alone pneumatic tourniquet with pressure adjustment and integrated timer function was located behind the anaesthesia machine to conceal the RIC or sham RIC treatment from anaesthesiologists, surgeons, and other staff. To conceal the treatment assignment in the ICU, the pneumatic tourniquet was operated behind a screen.
Anaesthesia and postoperative care in the ICU were provided according to the institutional standard of care. Briefly, anaesthesia was induced using midazolam (0.05e0.07 mg kg À1 ) and sufentanil (1.5e2 mg kg À1 ), and maintained using sevoflurane in oxygen (40%)/air mixture and continuous administration of sufentanil at 0.5e1.5 mg kg À1 h À1 . CPB was with nonpulsatile flow, blood-containing cold cardioplegia, and a-stat management at 32e34 C. The haematocrit was maintained at >20% during CPB with ultrafiltration or transfusion of packed red blood cells. After CPB, packed red blood cells were transfused when the haematocrit decreased to <24%. Salvaged blood from the CPB circuit was processed using a cell salvage system, and administered after CPB. Norepinephrine was used as a first-line vasopressor, and vasopressin at an infusion rate of 2.4e4 unit h À1 was added when norepinephrine (up to 0.3 mg kg À1 min À1 ) was insufficient to maintain the target mean arterial pressure (!65 mm Hg). Milrinone was used in cases of ventricular systolic dysfunction or pulmonary hypertension. For fluid resuscitation, balanced synthetic colloid (Volulyte; Fresenius Kabi, Bad Homburg, Germany) (up to a maximal dose of 15 ml kg À1 day
À1
) and balanced crystalloid (plasma solution A; CJ, Seoul, Korea) [6e8 ml kg À1 h À1 (intraoperatively) and 2e4 ml kg À1 h À1 (after operation)] were used.
Serum creatinine concentrations were measured before operation, and at postoperative 6, 24, 48, 72, and 120 h. Subject characteristics, including preoperative co-morbid conditions, medications, and operative and perioperative data, which include fluid requirement, urine output, transfusion, chest tube drainage, furosemide dose, and requirement for vasopressor/inotropes during surgery until postoperative 48 h, were recorded. Haemodynamic variables, including cardiac index, were recorded at the end of surgery, and postoperative 24 and 48 h. Creatine kinase-MB, haematocrit, leucocyte count, and serum albumin concentrations were measured before operation, and at postoperative 24 and 48 h.
Study endpoints
The primary endpoint was the incidence of AKI after surgery. According to the Kidney Disease: Improving Global Outcomes criteria, 13 AKI was defined as any of the following: increase in serum creatinine by !26.5 mmol L À1 within 48 h; or increase in serum creatinine to !1.5 times the baseline value, which is known or presumed to have occurred within the prior 7 days; or presence of oliguria, which is defined as urine output <0.5 ml kg À1 h À1 for 6 h within postoperative 48 h. AKI was staged as follows: Stage 1, 1.5e1.9 times the baseline or !26.5 mmol L À1 increase in serum creatinine or urine output <0.5 ml kg À1 h À1 for 6e12 h; Stage 2, serum creatinine 2.0e2.9
times the baseline or urine output <0.5 ml kg À1 h À1 for !12 h;
and Stage 3, serum creatinine 3.0 times the baseline or increase in serum creatinine to !354 mmol L À1 or initiation of renal replacement therapy or urine output <0.3 ml kg À1 h À1 for !24 h or anuria for !12 h. The secondary endpoints included the incidence of each stage of AKI; requirement for renal replacement therapy; incidence of a composite of morbidity and mortality endpoints consisting of permanent stroke, sternal wound infection, newly developed atrial fibrillation, mechanical ventilation >24 h, reoperation for bleeding, and in-hospital or 30-day mortality; and duration of ICU stay and hospitalisation.
Statistical analysis
According to our institutional database of electronic medical records, the incidence of AKI in the control group was expected to be 30%. Under the assumption that RIC would decrease the incidence of AKI to 15%, at least 120 patients were required per group when simulating the probability of a Type I error at 0.05 and a Type II error at 0.2. Considering a 5% dropout rate, the sample size was set at 126 patients per group.
Continuous variables were analysed using independent ttest or ManneWhitney U-test, according to the results from the ShapiroeWilk test for normality. Serially measured data were analysed by repeated measures analysis of variance.
Categorical variables were analysed using the c
test or
Fisher's exact test. P-values for multiple comparisons were adjusted by Bonferroni's method. All analyses were performed using SPSS 23 (IBM Corp., Armonk, NY, USA). P-values <0.05 were considered statistically significant.
Results
Two subjects in the control group and six subjects in the RIC group revoked their consent when they were asked whether they would continue to participate in the study before the application of RIC or sham treatment in the ICU. A total of 124 subjects in the control group and 120 subjects in the RIC group completed the study, and were included in the analysis (Fig. 1) . The subjects' characteristics, including preoperative comorbid conditions, medications, and type of operation, were comparable between groups ( Table 1) .
The incidence of AKI was not significantly different between the control and RIC groups [19.4% vs 15.8%, respectively, a difference of 3.5 percentage points; 95% confidence interval (CI): e6.8%e13.9%; P¼0.470; Table 2 ]. The incidences of each stage of AKI, oliguria, and renal replacement therapy were not significantly different between the groups (all P>0.05). All patients who were diagnosed with AKI by urine output criteria also met the diagnosis by creatinine criteria. The mean serum creatinine concentrations throughout the study period were not significantly different (P¼0.494) between the groups ( . At all time points, the measured cardiac indices were similar in the two groups. Perioperative fluid balance, blood loss, and transfusion requirement were also not significantly different between the groups (Table 3 ). The concentrations of creatine kinase-MB, haemoglobin, white blood cell count, and albumin measured before operation and at 24 and 48 h after surgery were comparable between the two groups ( Table 4) .
The incidences of a composite of morbidity endpoints and mortality were not significantly different between the control (46.0%) and RIC (39.2%) groups (a difference of 6.8 percentage points; 95% CI: e6.4 to 20.0; P¼0.283) ( Table 5 ). The median duration of ICU stay and hospitalisation was not significantly different between the two groups ( Table 5) .
Discussion
RIC applied on the thigh upon the removal of the aortic crossclamp and repeated at postoperative 12 and 24 h did not significantly reduce the incidence of either AKI or renal 4, 5 However, RIC treatment was performed only once after the induction of anaesthesia. Also, most of the enrolled patients had coronary artery disease and received propofol, which may attenuate the RIC-induced protection. 16 Additional possible explanations for the conflicting results on the renoprotective effect of RIC encompass heterogeneity in patient populations, including co-morbidities and preoperative medications, outcome measures based on diverse definitions, and varied timing and 'dose' of the conditioning stimulus.
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In comparison with previous studies using pre-CPB RIC, repeated RIC at postoperative 12 and 24 h, in addition to that given upon the removal of the aortic cross-clamp, may confer additive protection. Systemic inflammatory response after CPB and renal hypoperfusion as a result of haemodynamic deterioration during the early postoperative period are known to play important roles in the development of postoperative AKI. In experimental studies, the sustained anti-inflammatory or antioxidant effect provided by repeated RIC was suggested to provide additional long-term protection.
11,12 Thus, we hypothesised that repetition of RIC during the immediate postoperative period might extend the period of protection.
Prior experimental studies performed RIC daily or twice daily. 11, 12, 17, 18 For a more constant provision of the potentially protective stimulus during the critical period, we decided to apply the treatment upon reperfusion, and at 12 and 24 h after operation.
Despite the biological plausibility of our approach, repeated RIC did not significantly reduce the incidence of AKI, which may be attributable to several reasons. First, the organprotective effect of RIC against I/R injury has been suggested to be more effective in moderate-to high-risk patients. 8 RIC significantly reduced AKI incidence in high-risk patients, as identified with a Cleveland Clinic Foundation score 19 of !6, in a recent multicentre trial by Zarbock and colleagues. 3 Notably, reduced incidence of AKI was prominent in more severe forms (AKI stages 2 and 3, and need for renal replacement therapy) in that study. In contrast, only five of our studied patients had a Cleveland Clinic Foundation score of !6 and the overall incidence of AKI was low, with most patients in the present study having Stage 1 disease. Second, many studies have shown that several comorbidities and medications can interfere with the efficacy of RIC-induced protection. 6 Some of those factors, such as diabetes, old age, beta-blockers, and statins, can be frequently found in patients undergoing cardiovascular surgery and can potentially negate the effect of RIC. We did not exclude those patients to avoid compromising the generalisability of the results. Third, the choice of anaesthetics can also influence the effect of RIC. Propofol, which is known to attenuate the protective effect of RIC, 16 was not used in the present study. The inhalation anaesthetics and opioids used in this study are known to be protective against I/R injury via the activation of the signalling pathway involving various protein kinases and ATP-sensitive potassium channels in a similar manner to RIC. 20 When both the anaesthetic and RIC are applied simultaneously, the interaction between them is not yet elucidated.
Owing to the shared signalling pathways, ischaemic-and volatile-anaesthetic-induced conditioning can act additively. 21 However, clinical studies have not found evidence for an additive effect of RIC in the presence of anaestheticinduced conditioning. 22 In addition, a meta-analysis suggested that volatile anaesthetics might be associated with attenuated response to RIC. 23 This study has some limitations. First, the sample-size calculation based upon both a 30% incidence of AKI and a 50% reduction in AKI with RIC was probably unrealistic. The numerical difference in the incidence of AKI in this study may be considered to be clinically relevant; however, this study was under-powered to detect this treatment effect. The results in this study were also imprecise (wide confidence intervals), and the statistically negative results might have been falsenegative findings (or Type II error). Second, the patients were not completely blinded to the RIC procedure. The first conditioning stimulus was applied to anaesthetised patients; however, the second and third stimuli were performed at postoperative 12 and 24 h, during which most patients were fully awake and others were sedated. Different levels of sedation at postoperative 12 and 24 h might have confounded the effect of RIC, as several studies have found that pain is one of the important triggers of RIC. 24 In conclusion, repeated RIC immediately, and 12 and 24 h after the release of the aortic clamp, did not significantly reduce the incidence and degree of AKI after valvular heart surgery. The occurrences of a composite of morbidity and mortality endpoints were also not significantly different in the RIC and control groups. 
